Skip to main content
Log in

Hormonal and behavioral effects associated with intravenousl-tryptophan administration

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Doses of 5.0, 7.5 and 10.0 gl-tryptophan, the amino acid precursor of serotonin, or saline alone were administered by IV infusion to a group of 11 healthy male subjects, and both hormonal and behavioral responses were monitored. Significant increases were observed in plasma concentrations of growth hormone and prolactin after all three doses ofl-tryptophan, but not after saline infusion. No alterations in cortisol or thryotropin were noted at any level. Examination of behavioral effects ofl-tryptophan revealed a dose-dependent impairment in performance on the symbol copying test. In addition,l-tryptophan produced significant effects on mental and physical sedation, but did not alter subjective ratings of tranquilization. In agreement with some prior reports, these observations support the ability ofl-tryptophan, when administered IV in high doses, to produce pronounced effects on the central nervous system in humans, and suggest the potential utility of this paradigm as a neuroendocrine challenge test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Anton-Tay F, Wurtman RJ (1971) Brain monoamines and endocrine function. In: Martini L, Ganong WF (eds) Frontiers in neuroendocrinology, Oxford University Press, New York, pp 45–66

    Google Scholar 

  • Ashcroft GW, Crawford TBB, Eccleston D, Sharman DF, McDougall EJ, Stanton JG, Binns JK (1966) 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 2:1049–1052

    Google Scholar 

  • Bergstrom DA, Kellar KJ (1979) Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimpramine treatment. J Pharmacol Exp Ther 209:256–261

    Google Scholar 

  • Bunney WE Jr, Davis JM (1965) Norepinephrine in depressive reactions. Arch Gen Psychiatry 13:483–494

    Google Scholar 

  • Charney DS, Heninger GR, Reinhard JF (1982) The effect of intravenousl-tryptophan on prolactin and growth hormone and mood in healthy subjects. Psychopharmacology 77:217–222

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE (1984) Serotonin function and mechanism of action of antidepressant treatment. Arch Gen Psychiatry 41:359–365

    Google Scholar 

  • Coppen AJ (1967) The biochemistry of affective disorder. Br J Psychiatry 113:1237–1264

    Google Scholar 

  • Coppen A, Eccleston EG, Peet M (1973) Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2:60–63

    Google Scholar 

  • Curzon G, Kantameneni BD, Van Boxel P, Gillman PK, Bartlett JR, Bridges PK (1980) Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients. Acta Psychiatr Suppl 280:3–19

    Google Scholar 

  • Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121

    Google Scholar 

  • Faber J, Hagen C, Kirkegaard C, Lauridsen UB, Muller SE (1977) Lack of effects ofl-tryptophan on basal and TRH-stimulated TSH and prolactin levels. Psychoneuroendocrinology 2:413–415

    Google Scholar 

  • Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173:149–152

    Google Scholar 

  • Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414–416

    Google Scholar 

  • Fraser WM, Tucker HSt, Grubb SR, Wigand JP, Blackard WG (1979) Effect ofl-tryptophan on growth hormone and prolactin release in normal volunteers and patients with secretory pituitary tumors. Horm Metab Res 11:149–155

    Google Scholar 

  • Fuxe K, Butcher LL, Engel J (1971)Dl-5-Hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol 23:420–424

    Google Scholar 

  • Gillman PK, Bartlett JR, Bridges PK, Kantameneni BD, Curzon G (1980) Relationship between tryptophan concentrations in human plasma, cerebrospinal fluid and cerebral cortex following tryptophan infusion. Neuropharmacology 19:1241–1242

    Google Scholar 

  • Glass AR, Smallridge RC, Schaff M, Diamond RC (1980) Absent prolactin response tol-tryptophan in normal and acromegalic subjects. Psychoneuroendocrinology 5:261–265

    Google Scholar 

  • Greenwood MH, Friedel J, Bond AJ, Curzon G, Lader MH (1974) The acute effects of intravenous infusion ofl-tryptophan in normal subjects. Clin Pharmacol Ther 16:455–464

    Google Scholar 

  • Handwerger S, Plonk JW, Lebovitz HE, Bivens CH, Feldman JM (1975) Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion in man. Horm Metab Res 7:214–216

    Google Scholar 

  • Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression. Arch Gen Psychiatry 41:398–402

    Google Scholar 

  • Imura H, Nakai Y, Yoshimi T (1973) Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J Clin Endocrinol Metab 36:204

    Google Scholar 

  • Kato Y, Nakai Y, Imura H, Chihara K, Ohgo S (1974) Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. J Clin Endocrinol Metab

  • Lal S, Young SN, Cervantes P, Guyda H (1980) Effect ofl-tryptophan on apomorphine-induced growth hormone secretion in normal subjects. Pharmakopsychiatrie 13:331–335

    Google Scholar 

  • Lancranjan I, Wirz-Justice A, Puhringer D, Del Pozo E (1977) Effect ofL-v-hydroxytryptophan unfusion on growth hormone, and prolactin secretion in man. J Clin Endocrinol Metab 45:588–593

    Google Scholar 

  • Lapin IP, Oxenkrug GF (1969) Intensification of the central serotonergic processes as a possible determinant of thymoleptic effect. Lancet 1:132–136

    Google Scholar 

  • Lucki I, Frazer A (1985) Changes in behavior associated with serotonin receptors following repeated treatment of rats with antidepressant drugs. In: Seiden LS, Balster RL (eds) Alan Liss Co, New York, pp 339–357

    Google Scholar 

  • MacIndoe JH, Turkington RW (1973) Stimulation of human prolactin secretion by intravenous infusion ofl-tryptophan. J Clin Invest 52:1972–1978

    Google Scholar 

  • Mason JW (1968) A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med 30:576–607

    Google Scholar 

  • Meltzer HY, Wiita B, Tricou BJ (1982) Effect of serotonin precursors and serotonin agonists on plasma hormone levels. In: Ho BT, Schoolar JC, Usdin E (eds) Serotonin in biological psychiatry. Raven Press, New York, pp 117–138

    Google Scholar 

  • Meltzer HY, Lowy M, Robertson A, Goodnick KP, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders III. Effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 41:391–397

    Google Scholar 

  • Modlinger RS, Schonmueller JM, Arora SP (1980) Adrenocorticotropin release by tryptophan in man. J Clin Endocrinol Metab 50:360–363

    Google Scholar 

  • Mueller EE, Brambilla F, Cavagnini F, Peracchi M, Panerai A (1974) Slight effect ofl-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab 39:1–5

    Google Scholar 

  • Norris H (1977) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10:181–191

    Google Scholar 

  • Pare CMB, Sandler M (1959) A clinical and biochemical study of a trial of iproniazid in the treatment of depression. J Neurol Neurosurg Psychiatry 22:247–251

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Chronic antidepressant treatment lowers spiroperidal-labeled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • van Praag HM (1974) Central monoamine deficiency in depressions: Causative or secondary phenomenon. Pharmakopsychiatry 8:321–326

    Google Scholar 

  • van Praag HM (1978) Amine hypothesis of affective disorders. In: Iversen LL, Iversen SD, Snyder SH (eds) Biology of mood and antianxiety drugs, vol 13. Plenum Press, New York, pp 187–297

    Google Scholar 

  • van Praag HM, Korf J, Puite J (1970) 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225:1259–1260

    Google Scholar 

  • Savage DD, Mendels J, Frazer A (1980) Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects of [H3] serotonin binding sites in rat brain. J Pharmacol Exp Ther 212:259–263

    Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522

    Google Scholar 

  • Segal DS, Kuczenski R, Mandell DJ (1974) Theoretical implications of drug-induced regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry 9:147–159

    Google Scholar 

  • Smythe GA, Compton PJ, Lazaru L (1976) Serotonergic control of human growth hormone secretion: The actions ofl-dopa andz-bromoergocrytise. In: Pecile A, Muller EE (eds) Growth hormone and related peptides. Excerpta Medica, Amsterdam, pp 222–235

    Google Scholar 

  • Strom-Olsen R, Weil Malherbe H (1958) Humoral changes in manic-depressive psychosis with particular reference to excretion of catecholamines in urine. J Ment Sci 104:696–704

    Google Scholar 

  • Wechsler D (1955) Manual for the wechsler adult intelligence scale. The Psychological Corporation, New York

    Google Scholar 

  • Weitzman ED, Fukashima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L (1971) The twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14–22

    Google Scholar 

  • Westenberg HGM, van Praag HM, de Jong JTVM, Thijssen JHH (1982) Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy. Psychiatr Res 7:361–371

    Google Scholar 

  • Winokur A, Amsterdam JD, Caroff S, Snyder PJ, Brunswick D (1982) Variability in hormonal response to a series of neuroendocrine challenges (TRH, GnRH, ITT, DST) in depressed patients. Am J Psychiatry 139:39–44

    Google Scholar 

  • Wirz-Justice A, Purhringer W, Lacoste V, Graw P, Gastpar M (1976) Intravenous 1-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Pharmakopsychiatrie 9:277–288

    Google Scholar 

  • Woolf PD, Lee L (1977) Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. J Clin Endocrinol Metab 45:123–133

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winokur, A., Lindberg, N.D., Lucki, I. et al. Hormonal and behavioral effects associated with intravenousl-tryptophan administration. Psychopharmacologia 88, 213–219 (1986). https://doi.org/10.1007/BF00652243

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00652243

Key words

Navigation